|

Renal Autologous Cell Therapy (REACT) Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 3: 1

Top Sponsors

  • Prokidney2

Indications

  • Chronic Kidney Diseases2
  • Diabetes2
  • Diabetic Kidney Disease1
  • Type 2 Diabetes Mellitus1

Huntsville, Alabama1 trial

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Nephrology Consultants

Phase 3

Meridian, Idaho1 trial

A Long-Term Follow-Up Study of Participants Exposed to REACT

Boise Kidney & Hypertension Institute

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.